These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 16199429

  • 21. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 22. [Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome].
    Pekhlivanov B, Mitkov M, Kavŭrdzhikova S.
    Akush Ginekol (Sofiia); 2006 Aug; 45(6):29-35. PubMed ID: 17168480
    [Abstract] [Full Text] [Related]

  • 23. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.
    Glueck CJ, Golnik KC, Aregawi D, Goldenberg N, Sieve L, Wang P.
    Transl Res; 2006 Nov; 148(5):215-22. PubMed ID: 17145568
    [Abstract] [Full Text] [Related]

  • 24. [Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].
    Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U.
    Minerva Ginecol; 2012 Feb; 64(1):23-9. PubMed ID: 22334228
    [Abstract] [Full Text] [Related]

  • 25. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.
    Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
    [Abstract] [Full Text] [Related]

  • 26. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ, Goldenberg N, Sieve L, Wang P.
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [Abstract] [Full Text] [Related]

  • 27. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
    Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM.
    Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
    [Abstract] [Full Text] [Related]

  • 28. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB, Bagis T, Zeyneloglu HB, Tarim E, Aslan E, Haydardedeoglu B, Erkanli S.
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [Abstract] [Full Text] [Related]

  • 29. Metformin versus lifestyle changes in treating women with polycystic ovary syndrome.
    Curi DD, Fonseca AM, Marcondes JA, Almeida JA, Bagnoli VR, Soares JM, Baracat EC.
    Gynecol Endocrinol; 2012 Mar; 28(3):182-5. PubMed ID: 22309675
    [Abstract] [Full Text] [Related]

  • 30. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.
    Saleh AM, Khalil HS.
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):614-21. PubMed ID: 15225184
    [Abstract] [Full Text] [Related]

  • 31. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
    Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Sanchón R, San Millán JL, Escobar-Morreale HF.
    Diabetes Care; 2007 Sep; 30(9):2309-13. PubMed ID: 17536071
    [Abstract] [Full Text] [Related]

  • 32. Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome.
    Glueck CJ, Aregawi D, Agloria M, Winiarska M, Sieve L, Wang P.
    Metabolism; 2006 Dec; 55(12):1582-9. PubMed ID: 17142128
    [Abstract] [Full Text] [Related]

  • 33. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L.
    Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
    [Abstract] [Full Text] [Related]

  • 34. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
    Gerli S, Mignosa M, Di Renzo GC.
    Eur Rev Med Pharmacol Sci; 2003 May; 7(6):151-9. PubMed ID: 15206484
    [Abstract] [Full Text] [Related]

  • 35. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.
    Fux Otta C, Wior M, Iraci GS, Kaplan R, Torres D, Gaido MI, Wyse EP.
    Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739
    [Abstract] [Full Text] [Related]

  • 36. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW, Kilpatrick ES, Keevil BG, Coady AM, Atkin SL.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [Abstract] [Full Text] [Related]

  • 37. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
    Genazzani AD, Strucchi C, Luisi M, Casarosa E, Lanzoni C, Baraldi E, Ricchieri F, Mehmeti H, Genazzani AR.
    Gynecol Endocrinol; 2006 Jan; 22(1):36-43. PubMed ID: 16522532
    [Abstract] [Full Text] [Related]

  • 38. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J, Hill M, Stárka L, Cibula D, Snajderová M, Sulcová J, Vondra K, Bendlová B.
    Cas Lek Cesk; 2001 Nov 08; 140(22):688-94. PubMed ID: 11789058
    [Abstract] [Full Text] [Related]

  • 39. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
    Nawaz FH, Rizvi J.
    Gynecol Obstet Invest; 2010 Nov 08; 69(3):184-9. PubMed ID: 20029224
    [Abstract] [Full Text] [Related]

  • 40. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr 08; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.